Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Hospira, Inc., A Pfizer Company
EIR
•Hospira, Inc., A Pfizer Company•May 25, 2012

Hospira, Inc., A Pfizer Company – FDA EIR, May 25, 2012

Record Details

An FDA inspection of Hospira Inc. in McPherson, KS, was conducted from May 22 to May 25, 2012, primarily focusing on recent recalls and field alerts concerning overfilled Carpuject drug products. The investigation identified the root cause of these overfills as operator failure to follow proper sequencing during the filling process on a specific manufacturing line. This issue was compounded by a stressed workforce due to increased production demands. While no FDA Form 483 was issued during this inspection, a verbal observation was conveyed to management. This observation highlighted a delay in submitting required FDA Field Alerts within the mandated three-day timeframe following awareness of product non-conformance. Hospira had initiated several corrective actions to address the overfills. These included reprogramming equipment to enforce correct operational sequences, enhancing quality oversight for line restarts after downtime, revising batch records to specifically document overfills as critical quality non-conformances, and planning the implementation of an automated vision system across all Carpuject lines to detect excess fill volumes. Management acknowledged their responsibility to comply with the Food Drug & Cosmetic Act.

Company
Hospira, Inc., A Pfizer Company
Inspection date
May 25, 2012
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Matt Stober (company_representative)
  • Val Jensen (other)
  • Charlene B. Schlicklau (company_representative)
  • Andrew F. Knudten (recipient)
  • Janet Stevens (company_representative)
View Company Profile

ID · e15bd57a-7f1b-4a24-bcf7-97f066aae6f5

Violation Codes1
21 CFR 820.198

Full citation text and observation details available on the Dashboard.

Other documents for Hospira, Inc., A Pfizer Company
  • 483 - 2026-03-10March 10, 2026
  • 483 - 2025-01-17January 17, 2025
  • 483 - 2023-06-30June 30, 2023
  • EIR - 2020-01-17January 17, 2020
  • 483 - 2020-01-17January 17, 2020

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hospira, Inc., A Pfizer Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.